16:02 Dec 20
Shilpa Medicare Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Shilpa Medicare Ltd.
79/100 High Financial Strength
Quality30/100 Expensive Valuation
Valuation51/100 Technically Neutral
TechnicalSWOT
Strength
10
Weakness
3
Opportunity
1
Threat
0
7.95K
Market Cap (Cr)
130.18
PE Ratio
3.42
Price to Book Ratio
41.71
RSI
2.76 %
Net Profit Margin
SWOT
Download Our App On:
